After a court ruling in Delaware, Anthem has notified Cigna that their proposed $54 billion merger is off, but that doesn’t mean the two insurance companies are amicably parting ways.
Anthem has stated that it will not pay Cigna a $1.85 billion merger termination fee due to the company’s belief that Cigna did not meet the legal requirements for receiving the money.
“In light of yesterday’s decision and Cigna’s refusal to support the merger, however, Anthem has delivered to Cigna a notice terminating the Merger Agreement,” Anthem said in a statement.
“Cigna has failed to perform and comply in all material respects with its contractual obligations. As a result, Cigna is not entitled to a termination fee.”
Going on offense, Anthem blamed Cigna for “repeated willful breaches of the Merger Agreement,” and a “successful sabotage,” of its brand and business. Anthem further claimed the doomed acquisition resulted in massive damages which they plan to “vigorously pursue.”
In a counter-statement from Cigna, the insurer claimed Anthem willfully failed to pursue all legal avenues to obtain regulatory approval of the merger, and demanded the “prompt payment of the $1.85 billion reverse termination fee.”
This fee is in addition to a current $13 billion lawsuit for damages against Anthem for alleged harm that it caused Cigna and its shareholders.
Anthem and Cigna have been in legal disputes with each other since the US Justice Department won its antitrust case to block the merger of the two health insurers.
Full Content: Anthem
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas